Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis

Human Immunology

Volumn 73, Issue 2, 2012, Pages 201-205

  Sivaram, Gunisetty ^a   Tiwari, Santosh K ^a   Bardia, Avinash ^a   Anjum, Farha ^a   Vishnupriya, Satti ^b   Habeeb, Aejaz ^a   Khan, Aleem A ^a  

^a DECCAN COLLEGE OF MEDICAL SCIENCES   (India)

^b OSMANIA UNIVERSITY   (India)

Author keywords

CD14; Innate immunity; MIF; Polymorphisms; TLR4; Ulcerative colitis

Indexed keywords

CD14 ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; COLITIS, ULCERATIVE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNITY, INNATE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

EID: 84856350615     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.006     Document Type: Article

References (32)

1. Hogenova H.T., Tuckova L., Stepankova R., Hudcovic T., Jelinkova L.P., Kozakova H., et al. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann N Y Acad Sci 2005, 1051:787-798.
2. Stronati L., Negroni A., Pierdomenico M., D'Ottavio C., Tirindelli D., Di Nardo G., et al. Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis. Dig Liver Dis 2010, 42:848-853.
3. Calandra T. Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 2003, 35:573-576.
4. Roger T., David J., Glauser M.P., Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924.
5. Calvano J.E., Agnese D.M., Um J.Y., Goshima M., Singhal R., Coyle S.M., et al. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and Toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 2003, 20:415-419.
6. Obana N., Takahashi S., Kinouchi Y., Negoro K., Takagi S., Hiwatashi N., et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002, 37:699-704.
7. Wang F., Tahara T., Arisawa T., Shibata T., Nakamura M., Fujita H., et al. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol 2007, 22:925-929.
8. -159 C/T polymorphism on CD14 expression and the balance between proinflammatory and anti-inflammatory cytokines in whole blood culture. Shock 2007, 28:148-153.
9. Török H.P., Glas J., Tonenchi L., Mussack T., Folwaczny C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004, 112:85-91.
10. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., et al. Deficient host-bacteria interactions in inflammatory bowel disease?. The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53:987-992.
11. Lazarus R., Vercelli D., Palmer L.J., Klimecki W.J., Silverman E.K., Richter B., et al. Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 2002, 190:9-25.
12. Hise A.G., Hazlett F.E., Bockarie M.J., Zimmerman P.A., Tisch D.J., Kazura J.W. Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun 2003, 4:524-527.
13. Hartel Ch, Finas D., Ahrens P., Kattner E. Schaible Th, Muller D., et al. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Human Reprod 2004, 10:911-915.
14. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002, 186:1522-1525.
15. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002, 162:1028-1032.
16. Lewis J.D., Chuai S., Nessel L., Lichtenstein G.R., Aberra F.N., Ellenberg J.H. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008, 14. 1660-16.
17. Fei B.Y., Lv H.X., Yang J.M., Ye Z.Y. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008, 41:44-47.
18. Karhukorpi J., Yan Y., Niemela S.Valtonen, Koistinen P., Joensuu T., et al. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 2002, 128:326-332.
19. Morange P.E., Tiret L., Saut N., Luc G., Arveiler D., Ferrieres J., et al. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease. Eur J Human Gene 2004, 12:1041-1049.
20. Shen M., Vermeulen R., Rajaraman P., Menashe I., He X., Chapman R.S., et al. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. Environ Mol Mutagen 2009, 50:285-290.
21. Han S., Lan Q., Park A.K., Lee K.M., Park S.K., Ahn H.S., et al. Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol 2010, 71:727-730.
22. Eng H.L., Chen C.H., Kuo C.C., Wu J.S., Wang C.H., Lin T.M. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection. J Infect Dis 2003, 188:90-97.
23. Krayenbuehl P.A., Hersberger M., Truninger K., Müllhaupt B., Maly F.E., Bargetzi M., et al. Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis. Europ J Gastroenterol Hepatol 2010, 22:835-841.
24. Shiroeda H., Tahara T., Nakamura M., Shibata T., Nomura T., Yamada H., et al. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokines 2010, 51:173-177.
25. Admetlla A.F., Bosch E., Sikora M., Marquès-Bonet T., Ramírez-Soriano A., Muntasell A., et al. Balancing selection is the main force shaping the evolution of innate immunity genes. J Immunol 2008, 181:1315-1322.
26. Schulz S., Zissler N., Altermann W., Klapproth J., Zimmermann U., Gläser C., et al. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens. Int J Immunogenet 2008, 35:457-464.
27. Horie Y., Meguro A., Ota M., Kitaichi N., Katsuyama Y., Takemoto Y., et al. Association of TLR4 polymorphisms with Behçet's disease in a Korean population. Rheumatol 2009, 48:638-642.
28. Guo Q.S., Xia B., Jiang Y., Morré S.A., Cheng L., Li J., et al. Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients. Postgrad Med J 2005, 81:526-529.
29. Biebl A., Muendlein A., Kazakbaeva Z., Heuberger S., Sonderegger G., Drexel H., et al. CD14 C-159T and Toll-like receptor 4 Asp299Gly polymorphisms in surviving meningococcal disease patients. PLoS ONE 2009, 4:e7374.
30. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 2004, 5:417-425.
31. Gazouli M., Mantzaris G., Archimandritis A.J., Nasioulas G., Anagnou N.P. Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J Gastroenterol 2005, 11:7525-7530.
32. Kathrani A., House A., Catchpole B., Murphy A., German A., Werling D., et al. Polymorphisms in the Tlr4 and Tlr5 gene are significantly associated with inflammatory bowel disease in German Shepherd dogs. PLoS ONE 2010, 5:e15740.